Unknown

Dataset Information

Molecular subtypes predict second breast events of ductal carcinoma in situ after breast-conserving surgery.


ABSTRACT:

Purpose

Currently, the prognostic value of molecular subtypes in ductal carcinoma in situ (DCIS) remains unclear. In this study, we explored whether molecular subtypes could predict second breast events (SBEs) in patients after breast-conserving surgery (BCS).

Methods

From January 2008 to December 2016, 291 DCIS patients treated with BCS were retrospectively analyzed. Patients were classified into four molecular subtypes: luminal A, luminal B, human epidermal growth factor receptor 2 (HER2) overexpression, and triple-negative breast cancer (TNBC). The SBE incidence was calculated by the competing risk model and compared by Gray's test. The disease-free survival rates were estimated by the Kaplan-Meier method and compared by the log-rank test. Prognostic factors were evaluate

SUBMITTER: Yang Y 

PROVIDER: S-EPMC9302274 | biostudies-literature | 2022 Jul

REPOSITORIES: biostudies-literature